ATNM (actiniumpharma.com) Koefisien nilai perusahaan marang pendapatan

By leveraging a network of local laboratories in the US, Actinium Pharmaceuticals (ATNM) ensures ultra-fast delivery of short-lived isotopes. An academic approach and R&D budgets enable the company to attract leading oncologists to develop leukemia therapies. The company's price-to-sales ratio on this GURU.Markets chart is recorded at 175.14, confirming the value of "smart bombs"—innovations that destroy blood cancer cells without damaging organs.
Rincian metrik keuangan lan pasar Actinium Pharma (ATNM)

For the biopharmaceutical sector, given the high dependence of Actinium Pharmaceuticals (ATNM) on external nuclear capacities and CMOs, this indicator serves as a tool for assessing the business's market attractiveness. By analyzing the enterprise value-to-revenue ratio, an investor compares the total enterprise value minus net debt against sales volume, which allows for the identification of asset overvaluation considering its capital-intensive outsourcing.